Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.
Carlisle JW, Jansen CS, Cardenas MA, Sobierajska E, Reyes AM, Greenwald R, Del Balzo L, Prokhnevska N, Kucuk O, Carthon BC, Mullane PC, Osunkoya A, Baumgarten D, Hosseinzadeh F, Wilkinson S, Lake R, Sowalsky AG, Liu Y, Master VA, Bilen MA, Kissick H.
Carlisle JW, et al. Among authors: bilen ma.
J Immunother Cancer. 2022 Jul;10(7):e004803. doi: 10.1136/jitc-2022-004803.
J Immunother Cancer. 2022.
PMID: 35863822
Free PMC article.